Pharmacokinetic considerations in Roux-en-Y gastric bypass patients.

N. Smith, April; Henriksen, B.; Cohen, A.

doi:10.2146/ajhp100630

Public

Pharmacokinetic considerations in Roux-en-Y gastric bypass patients.

Shared by NobleBlocks on Dec 1, 2011 • 12:00 AM UTC

Authors:

Smith A

Henriksen B

Cohen A

Abstract

Purpose Pharmacokinetic considerations in patients who have undergone Roux-en-Y gastric bypass (RYGB) are explored.Summary The prevalence of obesity, especially morbid obesity, has dramatically increased in recent years. In response, the number of bariatric surgeries performed has risen sharply, as ...

Discussions